Laboratorio Nazionale CIB, Area Science Park, Trieste, Italy.
Cell Cycle. 2010 Jul 15;9(14):2777-81. Epub 2010 Jul 7.
Oncogene-induced senescence (OIS) is a cellular defense mechanism against excessive mitogenic signaling and tumorigenesis. One of the major pathways required for OIS is the p53 tumor suppressor pathway. Consequently, many human tumors harbor p53 mutations while others show a dysfunctional p53 pathway, frequently by unknown mechanisms. We recently identified BRD7 as a potential tumor suppressor gene acting as a transcriptional cofactor for p53, affecting histone acetylation, p53 acetylation, and promoter activity on a subset of p53 target genes. We further found low BRD7 expression specifically in a subgroup of human breast tumors harboring wild-type, but not mutant, p53 and showed that one of the responsible mechanisms is deletion of the BRD7 gene locus. Here we further discuss the role of BRD7 as a cofactor in transcriptional regulation and highlight its role as a tumor suppressor via association with p53 and other tumor suppressor proteins.
癌基因诱导的衰老(OIS)是细胞针对过度有丝分裂信号和肿瘤发生的一种防御机制。OIS 所必需的主要途径之一是 p53 肿瘤抑制途径。因此,许多人类肿瘤携带 p53 突变,而另一些则显示出功能失调的 p53 途径,通常是通过未知的机制。我们最近发现 BRD7 是一种潜在的肿瘤抑制基因,作为 p53 的转录共因子发挥作用,影响组蛋白乙酰化、p53 乙酰化和一组 p53 靶基因的启动子活性。我们进一步发现,BRD7 表达水平低的情况特别存在于一组携带野生型而非突变型 p53 的人类乳腺癌肿瘤中,并表明负责该机制之一是 BRD7 基因座缺失。在这里,我们进一步讨论了 BRD7 作为转录调节辅助因子的作用,并强调了其通过与 p53 和其他肿瘤抑制蛋白的关联作为肿瘤抑制因子的作用。